Home > Press > Mentor Capital Signs $6M Nanotechnology Cancer LOI
Abstract:
Mentor Capital, Inc. (OTC Markets: MNTR) announced it has executed a Letter of Intent with Nanovega, Inc. for $6 million to fund the production scale up of its ultra-small synthetic antibodies. These nano-scale molecules are approximately one-tenth the size of most alternative cancer delivery bio-markers. The small size allows the nano-bodies to slip throughout solid tumors instead of piling up at the surface as is often currently encountered in cancer treatment.
Marek Malecki, MD, PhD, President of Nanovega, Inc., looks ahead, "We are enthusiastic about the financial support provided by Mentor Capital. With intellectual property protected [9 patents and applications] we look to scale up production of our unique synthetic antibodies." The nano-bodies are already produced for use by outside researchers and designed for multiple diagnostic and therapeutic applications.
Mentor Capital CEO, Chester Billingsley, adds, "We are especially intrigued by Nanovega's ability to tag cancer cells or fragments circulating in the blood with ultra-small metal atoms." The metal nano-tags allow the cancer cells to be separated out using a magnetic field. The separated cancer cells may then be quickly grown and tested outside the body to predetermine the most effective chemotherapy to prescribe.
####
About Mentor Capital, Inc.
By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading companies that reduce the cost of medical treatments, especially in the fight against cancer. Additional important information is presented at: www.MentorCapital.com
Forward Looking Statements, Safe Harbor and Risk Descriptions are Incorporated by Reference from the MNTR Company Web Site above.
For more information, please click here
Contacts:
Mentor Capital, Inc.
Chester Billingsley, CEO
(760) 788-4700
Copyright © BusinessWire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
High-tech 'paint' could spare patients repeated surgeries March 8th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||